Processa Pharmaceuticals, Inc. Share-based Payment Arrangement, Expense
Processa Pharmaceuticals, Inc. (PCSA) reported Share-based Payment Arrangement, Expense of $92.11 thousand for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:AllocatedShareBasedCompensationExpense · last filed 2026-08-14
- Processa Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2026-06-30 was $92.11K, a 54.68% decline year-over-year.
- Processa Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2026-03-31 was $95.96K, a 57.86% decline year-over-year.
- Processa Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2025-12-31 was $123.54K, a 20.32% decline year-over-year.
- Processa Pharmaceuticals, Inc. share-based payment arrangement, expense for the quarter ending 2025-09-30 was $303.05K, a 96.54% increase year-over-year.
- Processa Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2025 was $857.55K, a 36.22% increase from fiscal 2024.
- Processa Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2024 was $629.51K, a 73.45% decline from fiscal 2023.
- Processa Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2023 was $2.37M, a 73.14% decline from fiscal 2022.
- Processa Pharmaceuticals, Inc. share-based payment arrangement, expense for fiscal 2022 was $8.83M, a 458.43% increase from fiscal 2021.
| Period end | Share-based Payment Arrangement, Expense 3 month | Share-based Payment Arrangement, Expense 3 month as first filed | Share-based Payment Arrangement, Expense 6 month | Share-based Payment Arrangement, Expense 6 month as first filed | Share-based Payment Arrangement, Expense 9 month | Share-based Payment Arrangement, Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $92.11K 10-Q · filed 2026-08-14 | $188.07K 10-Q · filed 2026-08-14 | $311.61K derived: sum of 3 quarters · filed 2026-08-14 | $614.66K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2026-03-31 | $95.96K 10-Q · filed 2026-05-07 | $219.51K derived: sum of 2 quarters · filed 2026-05-07 | $522.55K derived: sum of 3 quarters · filed 2026-05-07 | $725.80K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-12-31 | $123.54K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $426.59K derived: sum of 2 quarters · filed 2026-03-18 | $629.84K derived: sum of 3 quarters · filed 2026-08-14 | $857.55K 10-K · filed 2026-03-18 | ||
| 2025-09-30 | $303.05K 10-Q · filed 2025-11-06 | $506.30K derived: sum of 2 quarters · filed 2026-08-14 | $734.01K 10-Q · filed 2025-11-06 | $889.06K derived: sum of 4 quarters · filed 2026-08-14 | ||
| 2025-06-30 | $203.25K 10-Q · filed 2026-08-14 | $203.25K 10-Q · filed 2025-08-07 | $430.96K 10-Q · filed 2026-08-14 | $430.96K 10-Q · filed 2025-08-07 | $586.01K derived: sum of 3 quarters · filed 2026-08-14 | $740.20K derived: sum of 4 quarters · filed 2026-08-14 |
| 2025-03-31 | $227.71K 10-Q · filed 2026-05-07 | $382.76K derived: sum of 2 quarters · filed 2026-05-07 | $536.95K derived: sum of 3 quarters · filed 2026-05-07 | $689.58K derived: sum of 4 quarters · filed 2026-05-07 | ||
| 2024-12-31 | $155.05K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-18 | $309.24K derived: sum of 2 quarters · filed 2026-03-18 | $461.87K derived: sum of 3 quarters · filed 2026-03-18 | $629.51K 10-K · filed 2026-03-18 | ||
| 2024-09-30 | $154.19K 10-Q · filed 2025-11-06 | $306.82K derived: sum of 2 quarters · filed 2025-11-06 | $474.47K 10-Q · filed 2025-11-06 | |||
| 2024-06-30 | $152.63K 10-Q · filed 2025-08-07 | $320.27K 10-Q · filed 2025-08-07 | ||||
| 2024-03-31 | $167.64K 10-Q · filed 2025-05-08 | |||||
| 2023-12-31 | $2.37M 10-K · filed 2025-03-20 | |||||
| 2022-12-31 | $8.83M 10-K · filed 2024-03-29 | |||||
| 2021-12-31 | $1.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-30 | $1.89M derived: sum of 2 quarters · filed 2022-03-30 | $1.58M 10-K · filed 2022-03-30 | |||
| 2021-09-30 | -$98.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | -$410.91K 10-Q · filed 2021-11-12 | ||||
| 2021-06-30 | -$312.29K 10-Q · filed 2021-08-12 | |||||
| 2020-12-31 | $383.57K 10-K · filed 2022-03-30 | |||||
| 2019-12-31 | $116.31K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $385.44K derived: sum of 2 quarters · filed 2020-03-06 | $451.92K derived: sum of 3 quarters · filed 2020-03-06 | $510.48K 10-K · filed 2020-03-06 | ||
| 2019-09-30 | $269.13K 10-Q · filed 2019-11-14 | $335.61K derived: sum of 2 quarters · filed 2019-11-14 | $394.16K 10-Q · filed 2019-11-14 | $417.70K derived: sum of 4 quarters · filed 2020-03-06 | ||
| 2019-06-30 | $66.48K 10-Q · filed 2019-08-14 | $125.03K 10-Q · filed 2019-08-14 | $148.57K derived: sum of 3 quarters · filed 2020-03-06 | $199.10K derived: sum of 4 quarters · filed 2020-03-06 | ||
| 2019-03-31 | $58.56K 10-Q · filed 2019-05-14 | $82.09K derived: sum of 2 quarters · filed 2020-03-06 | $132.62K derived: sum of 3 quarters · filed 2020-03-06 | |||
| 2018-12-31 | $23.54K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-06 | $74.06K derived: sum of 2 quarters · filed 2020-03-06 | $74.06K 10-K · filed 2020-03-06 | |||
| 2018-09-30 | $50.53K 10-Q · filed 2019-11-14 | $50.53K 10-Q · filed 2019-11-14 | ||||
| 2016-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $0.00 derived: sum of 2 quarters · filed 2017-09-25 | $1.63K derived: sum of 3 quarters · filed 2017-09-25 | $6.69K 10-K · filed 2017-09-25 | ||
| 2016-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2017-09-08 | $1.63K derived: sum of 2 quarters · filed 2017-09-08 | $6.69K 10-Q · filed 2017-09-08 | $19.44K derived: sum of 4 quarters · filed 2017-09-25 | ||
| 2016-06-30 | $1.63K 10-Q · filed 2017-08-30 | $6.69K 10-Q · filed 2017-08-30 | $19.44K derived: sum of 3 quarters · filed 2017-09-25 | $28.54K derived: sum of 4 quarters · filed 2017-09-25 | ||
| 2016-03-31 | $5.06K 10-Q · filed 2017-08-07 | $17.81K derived: sum of 2 quarters · filed 2017-09-25 | $26.91K derived: sum of 3 quarters · filed 2017-09-25 | $66.44K derived: sum of 4 quarters · filed 2017-09-25 | ||
| 2015-12-31 | $12.75K derived: 10-K 12 month − 10-Q 9 month · filed 2017-09-25 | $21.85K derived: sum of 2 quarters · filed 2017-09-25 | $61.38K derived: sum of 3 quarters · filed 2017-09-25 | $96.93K 10-K · filed 2017-09-25 | ||
| 2015-09-30 | $9.10K 10-Q · filed 2017-09-08 | $48.63K derived: sum of 2 quarters · filed 2017-09-08 | $84.18K 10-Q · filed 2017-09-08 | $105.85K derived: sum of 4 quarters · filed 2017-09-08 | ||
| 2015-06-30 | $39.52K 10-Q · filed 2017-08-30 | $75.08K 10-Q · filed 2017-08-30 | $96.75K derived: sum of 3 quarters · filed 2017-08-30 | $142.88K derived: sum of 4 quarters · filed 2017-08-30 | ||
| 2015-03-31 | $35.55K 10-Q · filed 2017-08-07 | $57.22K derived: sum of 2 quarters · filed 2017-08-07 | $103.36K derived: sum of 3 quarters · filed 2017-08-07 | $137.67K derived: sum of 4 quarters · filed 2017-08-07 | ||
| 2014-12-31 | $21.67K derived: 10-K 12 month − 10-Q 9 month · filed 2017-06-19 | $67.80K derived: sum of 2 quarters · filed 2017-06-19 | $102.12K derived: sum of 3 quarters · filed 2017-06-19 | $231.52K 10-K · filed 2017-06-19 | ||
| 2014-09-30 | $46.13K 10-Q · filed 2015-12-01 | $80.45K derived: sum of 2 quarters · filed 2015-12-01 | $209.85K 10-Q · filed 2015-12-01 | $358.72K derived: sum of 4 quarters · filed 2015-12-01 | ||
| 2014-06-30 | $34.31K 10-Q · filed 2015-08-19 | $163.72K 10-Q · filed 2015-08-19 | $312.58K derived: sum of 3 quarters · filed 2015-08-19 | $330.11K derived: sum of 4 quarters · filed 2015-08-19 | ||
| 2014-03-31 | $129.41K 10-Q · filed 2015-05-15 | $278.27K derived: sum of 2 quarters · filed 2015-05-15 | $295.80K derived: sum of 3 quarters · filed 2015-05-15 | $326.17K derived: sum of 4 quarters · filed 2015-05-15 | ||
| 2013-12-31 | $148.86K derived: 10-K 12 month − 10-Q 9 month · filed 2015-04-14 | $166.39K derived: sum of 2 quarters · filed 2015-04-14 | $196.76K derived: sum of 3 quarters · filed 2015-04-14 | $216.08K 10-K · filed 2015-04-14 | ||
| 2013-09-30 | $17.53K 10-Q · filed 2014-11-13 | $47.90K derived: sum of 2 quarters · filed 2014-11-13 | $67.22K 10-Q · filed 2014-11-13 | $93.77K derived: sum of 4 quarters · filed 2014-11-13 | ||
| 2013-06-30 | $30.37K 10-Q · filed 2014-08-19 | $49.69K 10-Q · filed 2014-08-19 | $76.24K derived: sum of 3 quarters · filed 2014-08-19 | $151.44K derived: sum of 4 quarters · filed 2014-08-19 | ||
| 2013-03-31 | $19.32K 10-Q · filed 2014-05-14 | $45.87K derived: sum of 2 quarters · filed 2014-05-14 | $121.07K derived: sum of 3 quarters · filed 2014-05-14 | $194.44K derived: sum of 4 quarters · filed 2014-05-14 | ||
| 2012-12-31 | $26.55K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $101.75K derived: sum of 2 quarters · filed 2014-03-27 | $175.12K derived: sum of 3 quarters · filed 2014-03-27 | $457.00K 10-K · filed 2014-03-27 | ||
| 2012-09-30 | $75.20K 10-Q · filed 2013-11-08 | $148.57K derived: sum of 2 quarters · filed 2013-11-08 | $430.45K 10-Q · filed 2013-11-08 | |||
| 2012-06-30 | $73.37K 10-Q/A · filed 2013-09-06 | $355.25K 10-Q/A · filed 2013-09-06 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| AMARIN CORP PLC\UK (AMRN) | $0.005B | -247.24 | |
| Xenetic Biosciences, Inc. (XBIO) | United States | $0.006B | |
| ProPhase Labs, Inc. (PRPH) | United States | $0.006B | -0.06 |
| Dermata Therapeutics, Inc. (DRMA) | United States | $0.005B | -0.62 |
| REVIVA PHARMACEUTICALS HOLDINGS, INC. (RVPH) | United States | $0.005B | |
| Cadrenal Therapeutics, Inc. (CVKD) | United States | $0.004B | -0.90 |
| Pulmatrix, Inc. (PULM) | United States | $0.006B | |
| Lakewood-Amedex Biotherapeutics Inc. (LABT) | United States | $0.004B | |
| Ernexa Therapeutics Inc. (ERNA) | United States | $0.006B | |
| 60 DEGREES PHARMACEUTICALS, INC. (SXTP) | United States | $0.004B | -0.59 |